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Received October 15, 2013; accepted January 14, 2014AbstractBackground: Moyamoya disease (MMD) is an uncommon cerebrovascular disorder characterized by idiopathic progressive stenosis or the
occlusion of the intracranial arteries. Digital subtraction angiography (DSA) is the reference diagnostic imaging modality for MMD. Use of the
conventional Suzuki grading remains the gold standard for evaluating the severity of MMD. In this study, we propose a quantitative method
using color-coded parametric quantitative DSA (QDSA) to improve prediction of the severity of MMD.
Methods: Eighteen DSA examinations from 18 patients with MMD and 14 control participants were included. All patients with MMD underwent
DSA and dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI). QDSA was used to determine the delay time of maximal
opacification (Td) between the internal carotid artery and the M2 segment of the middle cerebral artery. The time-to-peak (TTP) was measured in
the medial frontal, lateral frontal, parietal, and occipital lobes from the DSC-PWI. The relative TTP (rTTP) values were then obtained by
subtracting the TTP of the cerebellum.
Results: The Td was significantly longer in the patients with MMD presenting with infarction than in the control group. The Td significantly
correlated with the angiographic Suzuki grading system and showed closer correlation with prolonged rTTP in the medial frontal, lateral frontal,
and parietal regions compared with Suzuki grading.
Conclusion: The Td significantly correlated with conventional angiographic grading and with the status of hemodynamic impairment in patients
with MMD. QDSA and Td measurements can provide a simple and quantitative angiographic grading system for patients with MMD.
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Moyamoya disease (MMD) is a rare cerebrovascular dis-
order characterized by idiopathic progressive stenosis or by
intracranial artery occlusion.1 Stenosis begins in the supra-
clinoid portions of the internal carotid artery and can progress
to the proximal cerebral arteries. The conventional classifica-
tion scheme for digital subtraction angiography (DSA), Suzuki
grading, remains the reference standard for evaluating theociation. All rights reserved.
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the hemodynamic status of the whole brain parenchyma.2e4 In
addition, it provides qualitative information and is insensitive
to longitudinal follow-up.5 Previous studies have shown that
color-coded parametric quantitative DSA (QDSA) increases
the conspicuity of subtle blood flow changes6 and enables the
quantitative monitoring of hemodynamics in the angiographic
suite.7,8 For example, a study by Lin et al7 demonstrated the
feasibility of QDSA for the measurement of cerebral circula-
tion time as a surrogate hemodynamic marker in patients with
carotid stenosis.7
In this study, we hypothesized that QDSA could provide a
more sensitive indicator of disease severity than conventional
DSA. We measured the delay time of maximal opacification
(Td) between the internal carotid artery (ICA) and the middle
cerebral artery (MCA) in patients with MMD, and correlated
these Tds with the hemodynamic parameters obtained from
dynamic susceptibility-weighted perfusion-weighted magnetic
resonance imaging (DSC-PWI).
2. Methods2.1. Patient selectionThis study was approved by the Taipei Veterans General
Hospital Institutional Review Board. From March 2011 to
January 2013, 18 patients with MMD were referred for DSA
examination (mean age 22.8 years; range, 2e53 years; 7 men
and 11 women). The patients were prospectively enrolled into
our study and underwent DSA and DSC-PWI at intervals of
<3 months. Informed consent was obtained prior to con-
ducting DSA. Data on the control group were obtained from a
group of 14 patients with no evidence of hemodynamic ab-
normality (mean age, 46.6 years; range, 21e63 years).7Fig. 1. Left common carotid color-coded angiogram of a 26-year-old woman
with MMD. Four regions of interest: I1, cervical portion of the ICA; I2,
petrous portion of the ICA; I3, supraclinoid portion of the ICA; M2, the
midpoint of the MCA M2 segment. ICA ¼ internal carotid artery;
MCA ¼ middle cerebral artery; MMD ¼ moyamoya disease.2.2. Imaging protocol and data analysis
2.2.1. Cerebral angiography
All angiographic examinations were performed using a
biplane angiography suite (AXIOM-Artis; Siemens, Erlangen,
Germany). A 4 F angiocatheter was placed at the level of the
C4 vertebral body for DSA. The imaging parameters were six
frames per second for the DSA throughout the entire acqui-
sition series for 12 seconds or until maximal opacification of
the superior sagittal sinus.7,9 Twelve milliliters of a 60%
diluted contrast medium (340 mgI/mL) were injected into the
patients at a rate of 6e8 mL/s using a power injector (Liebel-
Flarsheim Angiomat Illumena; Cincinnati, OH, USA).
Two neuroradiologists, with 7 years and 5 years of expe-
rience, respectively, classified the stenoocclusive changes in
the ICA into six angiographic stages as defined by Suzuki
et al1,10: Stage I, narrowing of the carotid bifurcation only;
Stage II, dilation of the main cerebral arteries with the
appearance of moyamoya vessels; Stage III, partial disap-
pearance of the anterior and middle cerebral arteries with
increased moyamoya vessels around the circle of Willis; Stage
IV, advanced stenoocclusive changes in the ICA, with theanterior cerebral artery (ACA) and MCA traced very dimly or
in a completely different shape; Stage V, absence of the ACA
and MCAwith further reduction of the moyamoya vessels; and
Stage VI, blood supply from the external carotid artery only
and almost complete disappearance of the moyamoya vessels.
The final Suzuki grades were determined by consensus.
Subsequently, the DSA images were color-coded using
postprocessing software, syngo iFlow (Siemens Healthcare,
Siemens, Erlangen, Germany), based on the X-ray attenuation
along the angiographic frames.6,7 The time point at maximal
X-ray attenuation was defined as the time of maximal opaci-
fication (Tmax). Four regions of interest (ROIs), the distal
cervical, petrous, and supraclinoid portions of the ICA, as well
as the M2 of the MCA, were measured on the anteroposterior
DSA views. The Td of the MCAwas defined as the difference
in the Tmax between the M2 and the ICA (the average Tmax
of the distal cervical, petrous, and supraclinoid portions of the
ICA; Fig. 1). The same two neuroradiologists measured the
Tds independently, blinded to the perfusion and magnetic
resonance imaging (MRI) findings of the patients.
2.2.2. MRI and DSC-PWI
Brain MRI was obtained on a 1.5 T (Signa HD, GE
Healthcare, Milwaukee, WI, USA) or a 3 T scanner
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USA). Thereafter, DSC-PWI was acquired using a multislice
gradient-echo EPI pulse sequence [repetition time/echo time
(TR/TE), 1000/40 ms; flip angle, 60 on a 1.5 T scanner; or
TR/TE, 1000/27 ms; flip angle, 35 on a 3 T scanner]. The
matrix was 128  128 and the section thickness was 7 mm. An
intravenous single dose (0.5 mmol/mL, 0.2 mL/kg body
weight) of gadoterate meglumine (Gd-DOTA, Dotarem,
Guerbet, Roissy CdG, France), followed by 20 mL of normal
saline, was injected at a rate of 2e4 mL/s.
The DSC-PWI results were postprocessed using software
implemented on MATLAB (MathWorks, Inc, Natick, MA,
USA) as described previously.11 Briefly, the algorithm was
based on a mixture of multivariate gaussians and the
expectation-maximization algorithm initialized according to
the results of hierarchical clustering.12 The brain regions were
dissected automatically to extract various perfusion compart-
ments from DSC-PWI so that each compartment consisted of
pixels of similar signal-time curves. The perfusion parametric
maps in the slice that passed through the body of the lateral
ventricle were then evaluated. In each hemisphere, four ROIs
were drawn semiautomatically on the time-to-peak (TTP)
map: medial frontal region, lateral frontal region, parietal re-
gion, and occipital region (Fig. 2). The relative TTP (rTTP)Fig. 2. Dynamic susceptibility contrast perfusion-weighted imaging is
analyzed in the slice through lateral ventricles. Four regions of interest (medial
frontal, lateral frontal, parietal, and occipital regions) are drawn semi-
automatically in each hemisphere.was normalized by subtracting the TTP values of the
cerebellum.2.3. Statistical analysisAll statistical analyses were performed using SPSS 20.0
(IBM Corporation, Somers, NY, USA). The intraclass corre-
lation coefficient (ICC) with a 95% confidence interval (CI)
and absolute agreement was calculated to assess the interob-
server reliability of the Suzuki grading scores, the Tmax of
each ROI, and the Td measurements. The ICC values were
compared using the following scale: almost perfect agreement
(1.00e0.8), substantial agreement (0.8e0.6), moderate
agreement (0.6e0.4), fair agreement (0.4e0.2), and slight
agreement (<0.2). If the 95% CI of the ICC was zero, it
indicated nonsignificant correlation between the two ob-
servers' ratings. The KruskaleWallis test was used to compare
the Tds among the control group, patients without infarction,
and patients with infarction, and also to compare the Tds
among different types of infarction. Spearman rho correlations
were applied to compare the Tds among different Suzuki
stages and the correlations among the Tds, Suzuki stages, and
rTTPs. Correlations were considered significant if p < 0.05.
3. Results
Of the 18 examined patients, two had received a unilateral
extracranial-intracranial bypass, with the operated hemisphere
excluded. Therefore, this study included 34 carotid angio-
grams. According to the Suzuki grading system (mean;
3.32),1,10 two hemispheres were Stage I, 10 hemispheres were
Stage II, eight hemispheres were Stage III, five hemispheres
were Stage IV, seven hemispheres were Stage V, and two
hemispheres were Stage VI. The interval between DSA and
MRI ranged from 0 days to 21 days (mean; 3.8 days). We
divided the hemispheres into four groups: Group 1, asymp-
tomatic and no evidence of infarction (n ¼ 6); Group 2,
symptomatic, including transient ischemic attack or mild
ischemic symptoms, but no evidence of acute or old infarction
(n ¼ 8); Group 3, presence of acute or old infarction (n ¼ 18);
and Group 4, presence of intraparenchymal hemorrhage
(n ¼ 2). According to the patterns of infarction, 10 hemi-
spheres had lacunar infarcts, including one embolic infarct,
four watershed infarcts, and five territorial infarcts.
The Tmax at all ROIs and Td measurements showed sub-
stantial to perfect agreement between the two neuroradiolo-
gists' ratings (ICC range, 0.741e0.912). The neuroradiologists'
Suzuki grading results showed moderate agreement
(ICC ¼ 0.539; 95% CI, 0.223e0.755; Table 1). The Td of the
control group was 0.47 ± 0.26 seconds. The Td of the MMD
patients was measurable in 32 hemispheres. In two hemi-
spheres of Stage VI, the MCA was not opacified in the DSA
(mean, 0.97 ± 0.81 seconds; range, 0e3.5 seconds). The Tds
showed significant differences among the Suzuki stages
(p < 0.05, KruskaleWallis test). The Td was significantly
longer in the patients with MMD than in the control group
(p ¼ 0.002, ManneWhitney U test). The Tds of the patients
Table 1
Interobserver reliability of two physicians.
ROI (Tmax) ICC (95%, CI)
I1 0.741 (0.512, 0.871)
I2 0.858 (0.715, 0.932)
I3 0.858 (0.717, 0.932)
M2 0.877 (0.747, 0.943)
Delay time (Td) 0.912 (0.814, 0.959)
Suzuki grading 0.539 (0.223, 0.755)
CI ¼ confidence interval; ICC ¼ intraclass correlation coeffi-
cient; ROI ¼ region of interest.
Fig. 3. A significant correlation is noted between delay time (Td) and Suzuki
grading.
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toms displayed nonsignificant differences. The Tds in patients
with different patterns of infarction also displayed nonsignif-
icant differences.
The Suzuki grading scores, Tds, and rTTPs of the different
regions are shown in Table 2. We identified a strong correla-
tion between the Td and the Suzuki stages (r ¼ 0.798;
p < 0.001, Spearman rho correlation test; Fig. 3). The Td
showed significantly higher correlation with prolonged rTTP
in the medial and lateral frontal regions than the Suzuki
grading system (Fig. 4A and B). The Td correlated signifi-
cantly with the rTTP in the parietal region (Fig. 4C).
4. Discussion
The principal findings of this study were that the Td was
significantly prolonged in the patients with MMD compared
with the control group, and that the Td correlated with Suzuki
staging, and showed a higher correlation with the cerebral
perfusion abnormalities than conventional Suzuki staging. This
finding was not unexpected because Suzuki staging is primarily
based on the extent of basal stenoocclusive changes. Hemody-
namic changes are not considered in the Suzuki staging system.1
Recent advances in flat detector angiography and post-
processing software have enabled the quantitative evaluation of
time-density curves and the transit times of contrast media in
angiographic suites.6,7 When a comparable radiation dose is
applied to conventional DSA,13 flat detector DSA provides
higher temporal resolution imaging and richer hemodynamics
of vascular diseases. We used the frame rates of six frames per
second in the current study for moyamoya disease. The frameTable 2
Comparison between the delay time (Td), Suzuki grading, and hemodynamic
abnormalities.
Suzuki staging (n ¼ 34) Td (n ¼ 32)
Relative time to peak (rTTP)
Medial frontal region 0.392* 0.528**
Lateral frontal region 0.394* 0.495**
Parietal region NS 0.512**
Occipital region NS NS
Suzuki staging 0.798***
Data are Spearman rho correlation coefficients.
*p < 0.05.
**p < 0.01.
***p < 0.001.
NS ¼ not significant; Td ¼ delay time.rate is still suboptimal for high-flow cerebrovascular diseases,
such as dural arteriovenous fistula or arteriovenous malforma-
tion.9 The color-coding algorithm can enhance the subtle he-
modynamic changes on DSA images without extra radiation
doses and extra contrast medium. In this study, we measured the
Td of the MCA to determine the severity of MMD for two
reasons. First, the Td of the MCA represents the time interval
for a contrast bolus to travel from the internal carotid artery and
collateral arteries to the distal MCA, and can be used to estimate
the bolus delay and the degree of stenoocclusive change. Sec-
ond, several previous studies have observed that the cerebral
circulation time (CCT) is inversely correlated with the cerebral
blood flow (CBF)14,15 and the cerebrovascular reserve16 in pa-
tients with stenoocclusive arterial diseases. However, defining
the CCT in MMD is complicated using conventional DSA
because of reduced blood irrigation and flattening of the
contrast-filling slopes of the distal small arterial branches.17
Because the stenoocclusive changes in MMD predominantly
involve the circle of Willis, and the distal capillary bed and
venous system are fully dilated to compensate for reduced blood
flow, we hypothesized that the Td might play a key role in
defining the CCT and indicating the severity of MMD.
Because MMD is a disease associated with bilateral
involvement, and posterior cerebral artery involvement would
occur at relatively advanced stages of the disease, we used the
cerebellum as the internal reference for evaluation of the
perfusion impairment of both cerebral hemispheres. Our study
results showed that the Td of the MCA showed higher corre-
lation with the rTTP than with Suzuki staging. We used the
TTP of the time-signal curve as a parameter of perfusion. The
TTP map provides higher contrast-to-noise ratios than other
parametric mapping [e.g., CBF, cerebral blood volume (CBV),
and mean transit time (MTT)]. In addition, the TTP map is
independent of deconvolution algorithms or the selection of
the arterial input function.
Because of the combination of macro- and microvascular
information, the TTP is one of the most sensitive parameters
Fig. 4. Correlation between delay time (Td) and relative time-to-peak (rTTP) in (A) medial frontal region, (B) lateral frontal region, and (C) parietal regions.
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infarct core and penumbra18 and to determine the dif-
fusioneperfusion mismatch in several clinical trials.19e22 The
changes of TTP perfusion maps after revascularization surgery
were also correlated with clinical outcome in patients with
moyamoya disease.23 A study by Calamante et al22 effectively
demonstrated the dependency of the TTP on bolus delay and,
to a small degree, on the MTT. Therefore, the perfusion def-
icits in MMD might result from the delayed contrast bolus (as
indicated by the Td of the MCA). A prolonged Td of an artery
can indicate that its territorial tissues are at risk of hypo-
perfusion, although the collateral blood supply and cerebro-
vascular reactivity might have compensated and masked the
hemodynamic impairment. In regions with a long bolus delay,
even in a well-compensated status, tissues remain at higher
risk if the cerebral perfusion pressure declines further.
Several possible explanations could exist for the Td
showing nonsignificant differences between the patients with
infarction and those without infarction. First, patients with
MMD display various and characteristic infarct patterns.24
These patterns of infarction vary with age of onset and might
be associated with age-related selective vulnerability of the
cortical gray matter. Second, thrombus formation frequently
occurs in MMD, as identified in a previous histopathological
study.25 Investigators have also proposed that in addition tohypoperfusion of the progressive cerebral arteries, thrombo-
embolism underlies the development of large infarctions in
patients with MMD.24
It was reported that the mean dose-area product (DAP) of a
diagnostic cerebral angiography was 85.7 Gy$cm2 (mean,
68e149 Gy$cm2).13 It was also recommended that a complete
DSAworkup of moyamoya disease should include five vessels
(bilateral common carotid, external carotid, and 1 vertebral
artery).26 In the current study, the DAP per vessel (including
both posteroanterior (PA) and left lateral projections) from the
DSA automatic dose reports was approximately 30 Gy$cm2.
As a result, the total DAP of current comprehensive moya-
moya DSA workup was approximately 150 Gy$cm2. This
value is still similar to that reported in the literature.
This study suffers from several limitations. First, we showed
that Td can improve the prediction of hemodynamic status in
MMD using QDSA. However, we were unable to establish if
the Td can be used for the evaluation of patients who have
undergone bypass surgery or patients with other cerebral
stenoocclusive vasculopathy. Second, the Td was defined ac-
cording to the angiographic time-density curves. The parame-
ters of contrast medium administration in DSA (e.g., the
injection rate, injection volume, catheter tip, and the patient's
cardiac function) might alter the contrast bolus, resulting in
different shapes and waveforms of the time-density curves and
442 S.-C. Hung et al. / Journal of the Chinese Medical Association 77 (2014) 437e442Tmax.27 Standardizing the DSA procedures throughout the
entire study could have minimized these intramethod vari-
abilities. Finally, the Suzuki grading system and Td measure-
ments both focus predominantly on the stenoocclusive changes
in anterior circulation. Therefore, the extent and degree of
collaterals, particularly those from the posterior circulation, are
not effectively assessed, despite being critical in the tissue
salvaging of chronic cerebral ischemia.
In conclusion, the Td of the MCA provides closer corre-
lation with the hemodynamic severity of MMD than the
conventional Suzuki grading. Prolonged Td of the MCA cor-
responds with the degree of hemodynamic impairment in the
frontal and parietal regions in patients with MMD. The Td of
the MCA could provide a simple and quantitative angio-
graphic measurement for predicting cerebral perfusion status
in patients with MMD.
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